Compare IRWD & AHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IRWD | AHRT |
|---|---|---|
| Founded | 1998 | 1979 |
| Country | United States | United States |
| Employees | N/A | 98 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 526.7M | 455.6M |
| IPO Year | 2009 | 2013 |
| Metric | IRWD | AHRT |
|---|---|---|
| Price | $4.44 | $6.07 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | ★ $7.67 | $7.00 |
| AVG Volume (30 Days) | ★ 1.8M | 1.3M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 9.41% |
| EPS Growth | ★ 1400.00 | N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $298,276,000.00 | N/A |
| Revenue This Year | $57.95 | $846.44 |
| Revenue Next Year | $4.39 | $11.38 |
| P/E Ratio | $28.87 | ★ N/A |
| Revenue Growth | ★ 8.88 | N/A |
| 52 Week Low | $0.55 | $5.13 |
| 52 Week High | $5.78 | $6.11 |
| Indicator | IRWD | AHRT |
|---|---|---|
| Relative Strength Index (RSI) | 67.36 | 61.19 |
| Support Level | $3.07 | $5.50 |
| Resistance Level | $5.67 | $6.11 |
| Average True Range (ATR) | 0.23 | 0.16 |
| MACD | 0.14 | 0.07 |
| Stochastic Oscillator | 95.52 | 97.40 |
Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.
AH Realty Trust Inc is a real estate investment trust (REIT). It owns, operates, and acquires high-quality properties across the Mid-Atlantic and Southeast, creating lasting value for investors, partners, clients, tenants, and communities. The group focuses on operating and acquiring high-quality, well-positioned assets with growth potential and delivering long-term value for shareholders. Its portfolio includes Harbor Point, Southern Post, The Interlock, and Others.